Design [Regulatives / Guidelines]

posted by Pharma_88 – India, 2020-08-27 18:07 (1769 d 09:19 ago) – Posting: # 21893
Views: 9,211

Dear All,

We are thinking to perform steady state BE study for XXX submission where Test product is ER formulation and Reference product is IR formulation. Further, Its HVD product. So, question is whether is this feasible to conduct replicate BE IR vs ER and if yes then what are the parameters for conclusion?

Thanks.

Regards,
Pharma_88

Complete thread:

UA Flag
Activity
 Admin contact
23,425 posts in 4,928 threads, 1,677 registered users;
52 visitors (0 registered, 52 guests [including 7 identified bots]).
Forum time: 03:26 CEST (Europe/Vienna)

No problem can stand the assault of sustained thinking.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5